Podcasts about screening and prevention

Join us for our Ask the Experts: Advances in Type 1 Diabetes Screening and Prevention Everyone Should Know event where you'll learn about the newest advancements in screening and delaying the onset of type 1 diabetes. Listen as experts share their insights and advancements in the field. Whether you're a health care professional, a patient, or someone interested in the latest health trends, this is a must-attend event for anyone committed to understanding type 1 diabetes. Register for our upcoming Ask the Experts events at diabetes.org/experts.

Your Real Champion®: Dr. Angie Nicholas talks about grief and gratitude

Credits: 0.75 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/hiv-101-improving-access-to-screening-and-prevention  Overview: In the first episode of the three-part HIV 101 series, get a baseline understanding of HIV care today and learn just how simple HIV treatment is. Dr. Simmons and his guest cover topics such as syndemics, a status-neutral approach to screening, Undetectable = Untransmittable, and treatment as prevention. You will also learn about the critical role of primary care clinicians in improving access to care and reducing HIV-related stigma. 

Visit my Patreon page for a detailed summary of these guidelines with links, graphics, and more!#DoNoHarmTakeNoShitJoin the waitlist for Clear+Free: Your Holistic Solution to Persistent HPVEnroll in the Born Free MethodFind me on InstagramMidwife Collaborator Program(Looking for my other podcast? Go HERE for The Holistic OBGYN)**Medical Disclaimer: The Holistic OBGYN Podcast is an educational program. No information conveyed through this podcast should be construed as medical advice. These conversations are available to the public for educational and entertainment purposes only.

Fourteen thousand women are diagnosed with cervical cancer each year despite the effectiveness of vaccination and screening at preventing the disease. Dr. Huh is joined by Haller Smith, MD, a specialist in gynecologic oncology, to discuss strides in screening that have already reduced cervical cancer by 75%, as well as the obstacles to improving prevention even more. Dr. Smith discusses the latest screening and prevention guidelines, which emphasize the effectiveness of HPV vaccines and testing. The doctors discuss the promise of HPV self-sampling as one screening solution for those with limited access to health care.

Drive with Dr. Peter Attia Podcast Notes Key Takeaways Our brain needs sensory input and stimulation – if you don't have it, neuronal circuits don't get exercised and are more likely to atrophy; keep moving, keep diversifying cognitive experienceParkinson's disease is the fastest-growing neurodegenerative condition in the USWe're intervening in neurodegenerative disease too late – the current approach is the equivalent of taking a woman with stage 4 metastatic breast cancer and doing a lumpectomy Without biomarkers, we don't know the stages of neurodegenerative disease and when to apply which interventions“There's probably no activity that you can participate in that will have a greater impact on your brain's health than exercise.” – Dr. Peter AttiaExercise has the most potential to move the needle on brain health and brain health preventionNothing stimulates BDNF more than exercise: BDNF helps grow and protect new brain cells in memory centers of the brainInsights from continuous glucose monitors are profound, whether you wear it for a month or forever – it will change how you approach food and sleep more than other metrics like blood pressure which you measure at one point in time and don't know in betweenRead the full notes @ podcastnotes.org View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Kellyann Niotis is a neurologist specializing in risk reduction strategies for the prevention or slowing of neurodegenerative disorders. In this episode, Kellyann provides an overview of the various diseases associated with neurodegeneration, including, but not limited to, Alzheimer's disease, Lewy body dementia, and Parkinson's disease. She goes in-depth on Parkinson's disease, explaining its pathology, role in movement capacity, very early warning signs, and the role of anxiety and sleep. Similarly, she provides an in-depth discussion of Alzheimer's disease, including the latest in screening, genetics, and tools/strategies for prevention. She ties the discussion together by explaining the differences and commonalities among the various diseases of neurodegeneration and the potential causative triggers, and she highlights the importance of early screening, cognitive testing, and taking the proper steps to lowering the risk of disease. We discuss: Kellyann's background, training, and interest in the brain [2:30]; A primer on neurodegeneration: different types, prevalences, interventions, and more [5:30]; Overview of Parkinson's disease and neuromuscular disorders including ALS [16:00]; Parkinson's disease: early signs, diagnosis, genetics, causative triggers, and more [17:30]; Interventions to delay or avoid Parkinson's disease, and the role of sleep and anxiety [31:15]; The challenge of standardizing early interventions for Parkinson's disease without a clear biomarker [39:45]; Alzheimer's disease: pathophysiology and the role of the amyloid and tau proteins [47:45]; Can PET scans be informative for diagnosing Alzheimer's disease? [51:15]; Tau accumulation in the brain, tau scans, serum biomarkers, and possible early detection of Alzheimer's disease pathology [57:00]; Cognitive testing explained [1:03:30]; The challenge of identifying the stage of the disease and why drugs have not shown efficacy [1:14:45]; The association between hearing loss and dementia [1:17:45]; The relationship between oral health and neurodegenerative diseases [1:21:30]; Genetic risk for Alzheimer's disease [1:24:45]; What one's mitochondrial haplotype can reveal about their risk of neurodegenerative disease [1:32:30]; The positive impact of exercise on brain health [1:37:00]; High blood pressure as a risk factor [1:40:00]; Why women are disproportionately affected by Alzheimer's disease [1:44:15]; Final takeaways: the future of understanding neurodegenerative disease and further reducing risk [1:46:45]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

Drive with Dr. Peter Attia: Read the notes at at podcastnotes.org. Don't forget to subscribe for free to our newsletter, the top 10 ideas of the week, every Monday --------- View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Kellyann Niotis is a neurologist specializing in risk reduction strategies for the prevention or slowing of neurodegenerative disorders. In this episode, Kellyann provides an overview of the various diseases associated with neurodegeneration, including, but not limited to, Alzheimer's disease, Lewy body dementia, and Parkinson's disease. She goes in-depth on Parkinson's disease, explaining its pathology, role in movement capacity, very early warning signs, and the role of anxiety and sleep. Similarly, she provides an in-depth discussion of Alzheimer's disease, including the latest in screening, genetics, and tools/strategies for prevention. She ties the discussion together by explaining the differences and commonalities among the various diseases of neurodegeneration and the potential causative triggers, and she highlights the importance of early screening, cognitive testing, and taking the proper steps to lowering the risk of disease. We discuss: Kellyann's background, training, and interest in the brain [2:30]; A primer on neurodegeneration: different types, prevalences, interventions, and more [5:30]; Overview of Parkinson's disease and neuromuscular disorders including ALS [16:00]; Parkinson's disease: early signs, diagnosis, genetics, causative triggers, and more [17:30]; Interventions to delay or avoid Parkinson's disease, and the role of sleep and anxiety [31:15]; The challenge of standardizing early interventions for Parkinson's disease without a clear biomarker [39:45]; Alzheimer's disease: pathophysiology and the role of the amyloid and tau proteins [47:45]; Can PET scans be informative for diagnosing Alzheimer's disease? [51:15]; Tau accumulation in the brain, tau scans, serum biomarkers, and possible early detection of Alzheimer's disease pathology [57:00]; Cognitive testing explained [1:03:30]; The challenge of identifying the stage of the disease and why drugs have not shown efficacy [1:14:45]; The association between hearing loss and dementia [1:17:45]; The relationship between oral health and neurodegenerative diseases [1:21:30]; Genetic risk for Alzheimer's disease [1:24:45]; What one's mitochondrial haplotype can reveal about their risk of neurodegenerative disease [1:32:30]; The positive impact of exercise on brain health [1:37:00]; High blood pressure as a risk factor [1:40:00]; Why women are disproportionately affected by Alzheimer's disease [1:44:15]; Final takeaways: the future of understanding neurodegenerative disease and further reducing risk [1:46:45]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Kellyann Niotis is a neurologist specializing in risk reduction strategies for the prevention or slowing of neurodegenerative disorders. In this episode, Kellyann provides an overview of the various diseases associated with neurodegeneration, including, but not limited to, Alzheimer's disease, Lewy body dementia, and Parkinson's disease. She goes in-depth on Parkinson's disease, explaining its pathology, role in movement capacity, very early warning signs, and the role of anxiety and sleep. Similarly, she provides an in-depth discussion of Alzheimer's disease, including the latest in screening, genetics, and tools/strategies for prevention. She ties the discussion together by explaining the differences and commonalities among the various diseases of neurodegeneration and the potential causative triggers, and she highlights the importance of early screening, cognitive testing, and taking the proper steps to lowering the risk of disease. We discuss: Kellyann's background, training, and interest in the brain [2:30]; A primer on neurodegeneration: different types, prevalences, interventions, and more [5:30]; Overview of Parkinson's disease and neuromuscular disorders including ALS [16:00]; Parkinson's disease: early signs, diagnosis, genetics, causative triggers, and more [17:30]; Interventions to delay or avoid Parkinson's disease, and the role of sleep and anxiety [31:15]; The challenge of standardizing early interventions for Parkinson's disease without a clear biomarker [39:45]; Alzheimer's disease: pathophysiology and the role of the amyloid and tau proteins [47:45]; Can PET scans be informative for diagnosing Alzheimer's disease? [51:15]; Tau accumulation in the brain, tau scans, serum biomarkers, and possible early detection of Alzheimer's disease pathology [57:00]; Cognitive testing explained [1:03:30]; The challenge of identifying the stage of the disease and why drugs have not shown efficacy [1:14:45]; The association between hearing loss and dementia [1:17:45]; The relationship between oral health and neurodegenerative diseases [1:21:30]; Genetic risk for Alzheimer's disease [1:24:45]; What one's mitochondrial haplotype can reveal about their risk of neurodegenerative disease [1:32:30]; The positive impact of exercise on brain health [1:37:00]; High blood pressure as a risk factor [1:40:00]; Why women are disproportionately affected by Alzheimer's disease [1:44:15]; Final takeaways: the future of understanding neurodegenerative disease and further reducing risk [1:46:45]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

Dr. Gaggino has worked as a pediatrician for over 30 years on the west side of Michigan. She is the host of Pediatric Meltdown Podcast and founder of Medical Behavioral Health Solutions where you can get consultations on options for your practice. It is brought to you by Allied Physician Group, Pediatrics Meltdown, and The Pediatric Lounge.Help finding your state's child psychiatry access program- nncpap.orgBook: The Optimistic Child, By: Martin Seligman and Jane Gilham PhDBook: Good Inside: A Practical Guide to Becoming the Parent You Want to Be, By: Dr. Becky is an excellent resource for parentsBook: AAP publication Thinking Developmentally, By: Andy Garner and Robert SaulNIMH Toolkit-Pediatric Meltdown Podcast Lisa Horowitz “Screening for suicide in a busy pediatric practice”.Why Pediatricians are awesome: With a parent who lost her son to suicide:  With a medical student who struggled with suicidal ideation:  With PA who implemented the ASQ screen:  Link to podcast on financing mental health Also link to the Washington Collaborative Care AIMS website- Book: Prescriber's Guide to Psychopharmacology, By: Steven StahlPlease subscribe to our podcast on apple or amazon and give us a great review. You can make suggestions for guest and topics on our web site below. Thanks for listening. Follow us on social media YouTube,, Instagram, Web Page The Pediatric Lounge - A Podcast taking you behind the door of the Physician's Lounge to get a deeper insight into just what docs are talking about today, from the clinically profound to the wonderfully routine...and everything in between. The conversations are not intended as medical advice and the opinions expressed are solely those of the host and guest.

What is the role of modern technology, such as apps, when identifying suspicious skin lesions? How can we design and implement successful campaigns to increase awareness concerning the damaging impact of UV radiation on the skin? In today's episode, Prof. Jan Gutermuth moderates the discussion with Dr. Christian Posch who shares his expert insights concerning the importance of screening and identifying exogenous and endogenous risk factors of skin cancer. https://onlinelibrary.wiley.com/doi/10.1111/jdv.17660

In this episode, we speak with Dr. Jane Montealegre, the Deputy Director of the Office of Outreach and Health Disparities at Baylor College of Medicine. We learn about Dr. Montealegre's work on cervical cancer screening and prevention, including her ongoing research on mailed, self-collected HPV testing kits. In this podcast, we explore the future of cancer screening and prevention, and how to better reach underserved groups.

Dr. Jeffery Hebert, MD of WK Pierremont OB/GYN Specialists talks with us about Cervical Cancer Screening and Prevention.

As internists, we practice breast cancer screening and prevention at almost all annual physicals with our targeted population, how often is it though that we talk about it? For teaching us all about the screening and prevention of breast cancer, we have with us my amazing mentor from my time at Yale- Dr Erin Hofstatter. Join us in our conversation about lifetime risk of breast cancer, modalities and practices of screening and providing the best care for our patients.

WE’RE BACK!!! On today's episode of the Living Healthy Podcast, we're talking about Cancer Screening and Prevention with Dr. Rick Van Etten!

Amy Cohen Epstein sits down with Dr Julia Smith, Clinical Director of the Cancer Screening and Prevention Program at NYU Langone, to talk about the future of ovarian cancer prevention and research.The SEAMLynne Cohen FoundationGuest: Dr. Julia Smith Hosted on Acast. See acast.com/privacy for more information.

HOPA Now is the official podcast of the Hematology/Oncology/Pharmacy Association, an organization dedicated to supporting pharmacy practitioners and promoting the advancement of Hematology/Oncology/Pharmacy to optimize the care of individuals impacted by cancer.   These educational podcasts are part of our BCOP Preparatory and Recertification Course, which is designed to prepare oncology pharmacists preparing to sit for the BCOP Certification Exam, as well as meet the BPS requirement to complete a BCOP Preparatory/Recertification Review Course.   In this episode of HOPA Now, HOPA Fellow Dr. Robert Mancini shares information regarding cancer screening and prevention, including health and lifestyle factors, top genetic and familial risk factors, and effective pharmacological interventions. He concludes with an update on the ACS goal to increase cancer screening and prevention methods by the year 2035.   In this episode you will learn: Screening and prevention information What do we know about cancer prevention and risk factors? Understanding accurate guidelines for cancer prevention Additional recommendations include smoking cessation and use of sunscreen Pharmacological interventions — what really works? Average vs. high-risk cancer screening options and controversy Genetic and familial syndromes An update on the ACS 2035 challenge   Mentioned in This Episode: HOPA ACS 2035 Challenge   Quotes: “Education is the key to moving cancer prevention forward.” — Robert Mancini   “Rates of liver, pancreas, and uterine cancers will all increase if nothing is done to improve detection.” — Robert Mancini   “If major risk factors decrease and screening rates among Americans increase, … there will be an additional 20.5% drop of overall cancer deaths by the year 2035.” — Robert Mancini  

HEALTHY MONDAYS with AAPINA of NV- Oct. 15, 2018 - HIV Screening and Prevention Hosted by Dr. Marife Aczon-Armstrong of AAPINA of NVGuest: Raymond "Austin" Nation, PhD, RN, PHN ----Healthy Mondays is an independent production of AAPINA of Nevada. Contents of this podcast/radio program are solely produced and presented by The Asian American/Pacific Islander Nurses Association of Nevada. Contact AAPINA of Nevada through their website: http://aapina.org/about-us/aapina-of-nevada/

HEALTHY MONDAYS with AAPINA of NV- Oct. 15, 2018 - HIV Screening and Prevention Hosted by Dr. Marife Aczon-Armstrong of AAPINA of NVGuest: Raymond "Austin" Nation, PhD, RN, PHN ----Healthy Mondays is an independent production of AAPINA of Nevada. Contents of this podcast/radio program are solely produced and presented by The Asian American/Pacific Islander Nurses Association of Nevada. Contact AAPINA of Nevada through their website: http://aapina.org/about-us/aapina-of-nevada/

In recent years, breast cancer screening guidelines have changed to reduce the number of times a woman should be screened. Some women are concerned about their own preventive measures as a result of these changes. Dr. Tina Rizack, medical oncologist and former Women & Infants Hospital physician, discusses the current breast cancer screening and prevention guidelines.

Today we're discussing the serious topic of teen suicide with Jenna Glover, PhD, MS, of the Pediatric Mental Health Institute at Children's Colorado. Dr. Glover is the Director of Clinical Psychology Training at Children's Colorado and an assistant professor of child psychiatry at the University of Colorado School of Medicine. Mental health and suicide prevention resources from the episode: Primary care provider toolkit from the Suicide Prevention Resource Center PHQ-9 (.pdf) screening tool Columbia Suicide Severity Rating Scale (.pdf) "13 Reasons Why" Colorado Crisis Services Second Wind Fund National Suicide Prevention Line: 1-800-273-TALK (8255) MentalHealth.gov

Screening and Prevention of Colon Cancerwith guest Dr. Xavier Llor March 5, 2017 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Screening and Prevention of Colon Cancerwith guest Dr. Xavier Llor March 5, 2017 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Host: Brian P. McDonough, MD, FAAFP Dr. Randa Sifri is an Associate Professor of the Department of Family and Community Medicine in the Sydney Kimmel Medical College at Thomas Jefferson University, Director of Reasearch in the Department, and Research Fellowship Director. Listen as Dr. Brian McDonough interviews Dr. Sifri on early diagnosis, prevention, and recommended screenings for cancer in primary care patients.

Melanoma, the most dangerous type of skin cancer is a screenable, preventable cancer, yet one that is dramatically increasing. It is the leading cause of death from a skin disease.  Key to successful treatment of melanoma is understanding risks and recognizing symptoms early.

Dr Murat Tuncer talks to ecancer at the 2013 National Cancer Institute Directors Meeting (NCID 2013) in Lyon about the 81 cancer registries in Turkey, one in each city. The centers aim to gather a complete regional picture of incidence in Turkey and highlight needs for screening and prevention.

Don Dizon, MD Brown University